Details of the Drug Formulaction | DrugMAP

General Information of Drug Formulation (ID: F20926)

Formulation Name

Terazosin 1 mg capsule

Company

Clinical Solutions Wholesale; RemedyRepack

Pharmaceutical Drug(s) in Formulation

Drug Name	Drug ID	Indication	ICD 11	Status
Terazosin	DM3JCVS	Benign prostatic hyperplasia	GA90	Approved
--------------------

Pharmaceutical Excipient(s) in Formulation

Excipient Name	Excipient ID	PubChem CID	Functional Classification
Ferrosoferric oxide	E00231	14789	Colorant
Lactose monohydrate	E00393	104938	Binding agent; Diluent; Dry powder inhaler carrier; Lyophilization aid
Magnesium stearate	E00208	11177	lubricant
Silicon dioxide	E00670	Not Available	Anticaking agent; Opacifying agent; Viscosity-controlling agent
Sodium lauryl sulfate	E00464	3423265	Emulsifying agent; Modified-release agent; Penetration agent; Solubilizing agent; Surfactant; lubricant
Titanium dioxide	E00322	26042	Coating agent; Colorant; Opacifying agent

--------------------